Press Releases Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 05:38:29 2025-07-09 am EDT			5-day change	1st Jan Change
27.32 ^EUR	+0.51%		+3.33%	+41.56%

01:41am	Bayer Wins Maiden Approval For Menopausal Hot Flashes Medication From UK Regulator	MT
Jul. 08	German Equities Jump Amid EU-US Trade Deal Optimism	MT

Press Releases

BlueRock Therapeutics announces first patient receives investigational therapy in Phase 1/2a clinical trial of OpCT-001 for the treatment of primary photoreceptor diseases	Jul. 08	AQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Jul. 04	EQ
Bayer : U.S. Supreme Court asks for views of Solicitor General in Durnell case	Jun. 30	PU
Bayer : Eylea™ 8 mg with extended 6-month treatment interval approved in the EU	Jun. 27	PU
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Jun. 26	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Jun. 25	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Jun. 23	EQ
Bayer : CHMP recommends third indication for Bayer’s Nubeqa™ (darolutamide) for patients with advanced prostate cancer	Jun. 20	PU
Bayer Innovation Procurement Expands Use of Scientist.com's AI-Powered Platform for Global R&D Procurement Orchestration	Jun. 17	AQ
Bayer : files for approval of gadoquatrane in the U.S.	Jun. 17	PU
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	Jun. 12	EQ
Bayer : Simultaneous treatment start with Finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes	Jun. 05	PU
Bayer : Elinzanetant significantly reduces frequency of moderate to severe vasomotor symptoms associated with endocrine therapy for breast cancer in Phase III OASIS-4 study	Jun. 02	PU
Legal And Financial Fallout Of The Bayer-Monsanto Merger: A Cautionary Tale In M&A Due Diligence	May. 28	AQ
OTC Markets Group Welcomes Bayer AG to OTCQX	May. 23	AQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 21	EQ
Bayer : Articles of Incorporation of Bayer (articles of incorporation of bayer ag 2025)	May. 20	PU
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 20	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 19	EQ
Bayer : Presentation (dir bayer presentation 2025 05 13)	May. 16	PU
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 16	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 16	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	May. 15	EQ
Bayer : Transcript Q1 2025 Investor Call 2025-05-13	May. 14	PU
Bayer : 2025 Crop Science Investor Update	May. 14	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

BAYER : Potatoes may become a precious commodity

June 10, 2025 at 07:06 am EDT

Bayer, close to the final round(up)?

June 05, 2025 at 10:56 am EDT

Roundup: Bayer ordered to pay $2.1bn to an American suffering from cancer

March 24, 2025 at 06:21 am EDT